SUMNER GROUP HEALTH R&D LIMITED

Company number 13240512 · Monitor this company

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£1,386

Balance sheet as at 2025-03-31

View full accounts →

Overview

Company type: Private Limited Company
Incorporated: 2021-03-03
Employees: 0 (2025 accounts)
Registered office: 167 - 169 Great Portland Street, Fifth Floor, London, England, W1W 5PF
Postcode: W1W 5PF
Capital: 101 GBP
Accounts category: Micro

Accounts

Last made up to: 2025-03-31
Next due by: 2026-12-31
Financial year end: 31 March

Confirmation statement

Last statement dated: 2026-02-28
Next due by: 2027-03-14

View filing history →

Nature of business (SIC)

72110 Research and experimental development on biotechnology

Officers 1 current · 7 resigned

MR David James SUMNER Director

Appointed 2021-03-03

View all officers and resignations →

Group structure 1 subsidiary

SUMVAX LIMITED Active - Proposal to Strike off

From persons-with-significant-control filings on the public register.

At this address

31,542

companies are registered at this postcode →

Competitors London

1. DUKE STREET BIO LIMITED

£33,279,388
2. PURAFFINITY LTD

£21,442,940
3. RQBIO COVID LIMITED

£13,999,999
4. HEALTH INNOVATION HUB LIMITED

£11,778,337
5. PSIVAC LIMITED

£10,362,387

This company ranks 78 among research and experimental development on biotechnology in London.

Full league table →